Glycomics Advantage Prisyna leverages a novel glycomics-based approach for oral health, suggesting a unique value proposition that can be cross-sold to dental product distributors and clinics seeking differentiated mucosal care solutions.

Xerostomia Solution Existing MOISYN products target xerostomia and dry mouth, indicating a ready-to-market line addressing a common patient need that can be bundled with complementary dental hydration and oral comfort offerings.

Small, Agile With 11-50 employees and current revenue under one million, Prisyna presents a nimble partner for strategic collaborations, pilot programs, and co-development deals with larger medical device or OTC brands.

Strategic Partnerships As the oral health division of Synedgen, Prisyna can partner with larger healthcare and dental networks for distribution, veterinary or human oral care channels, and research collaborations leveraging glycopolymer tech.

Digital & Commerce Utilizing WordPress and Shopify with modern checkout options (Apple Pay, PayPal, Venmo) signals a consumer-facing e-commerce focus, offering opportunities to expand direct-to-consumer channels and wholesale conversions.